{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_182284.3:c.6056A>G",
          "cDNA Change": {
            "transcript": "NM_182284.3",
            "ref": "A",
            "alt": "G",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "A missense mutation in the kinase domain, leading to increased kinase activity and substrate phosphorylation."
        },
        {
          "HGVS": "NM_182284.3:c.4322G>C",
          "cDNA Change": {
            "transcript": "NM_182284.3",
            "ref": "G",
            "alt": "C",
            "position": "4322"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "A missense mutation in the GTPase domain, associated with altered kinase activity and phosphorylation of downstream substrates."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005163"
  },
  "Experiment Method": [
    {
      "Assay Method": "Kinase activity assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "Wild-type and variant LRRK2 proteins",
        "Description": "The experiment used recombinant LRRK2 proteins (wild-type, G2019S, and R1441C) for kinase activity measurements."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_182284.3:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The G2019S variant showed a 2.5-fold increase in kinase activity compared to wild-type LRRK2."
        },
        {
          "Variant": "NM_182284.3:c.4322G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The R1441C variant exhibited a 1.8-fold increase in kinase activity compared to wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 20% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity exceeding 50% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Substrate phosphorylation assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293 cells",
        "Description": "HEK293 cells were transfected with wild-type and variant LRRK2 constructs to measure substrate phosphorylation."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_182284.3:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The G2019S variant caused a 3.2-fold increase in phosphorylation of the substrate MAPT compared to wild-type."
        },
        {
          "Variant": "NM_182284.3:c.4322G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "The R1441C variant led to a 2.1-fold increase in phosphorylation of the substrate MAPT compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Substrate phosphorylation within 20% of wild-type levels.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Substrate phosphorylation exceeding 50% of wild-type levels.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}